BGTO
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
π¦πΊ ASX
π Performance
π΅ Cost
π Esg
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
N/A
Annual Growth
5 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
0
Pearlers Invested
Since January 2020
π Performance
Price History
N/A
1M
All Time
Graph
Table
Performance graph isn't available yet for this share
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in BGTO
0
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
N/A
β° Last time a customer invested in BGTO
N/A
BGTO investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in BGTO also invest in...
Want more shares? Try these...
Benjamin Hornigold Ltd is a AU-based company operating in industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2017-05-12. Benjamin Hornigold Limited is an Australia-based investment company. The investment objective of the Company is to achieve moderate to high portfolio returns over the medium to long term. The firm seeks to increase the value of its portfolio by allocating capital to investments in which it has the highest conviction. The company also focuses on providing investors with exposure to global and domestic investment opportunities in listed investments. The firm provides investors with the opportunity to gain exposure to an investment portfolio that is actively managed. The investment portfolio is invested in a small number of high conviction investments in undervalued assets that provide growth opportunities with the aim of achieving above average returns, (whilst limiting volatility) over the medium to long term. The firm delivers shareholder returns by providing an actively managed portfolio with diversification across products and global markets.
π Performance (5Yr p.a)
-14.79%
π Share price
$0.18 AUD
Bio-Gene Technology Ltd. engages in the research and development of the next generation of novel insecticides, addressing the problems of insecticide resistance and toxicity. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-29. Its technology is based on compounds with a novel mode of action proven to overcome insecticide resistance with minimal impact on human health and the environment. The Companyβs technology provides multiple potential new solutions in applications across crop protection, grain storage, public health, and consumer products. The company is developing and commercialising a broad portfolio of targeted insect control and pest management solutions. The firm's lead beta-triketone insecticide products include Flavocide and Qcide. Flavocide is a chemically synthesized product based on flavesone. Qcide is a natural oil product containing tasmanone as the active constituent. The firm operates in one business segment, being the conduct of research and development activities in the agricultural sector.
π Performance (5Yr p.a)
-15.88%
π Share price
$0.03 AUD
π§ͺ CHEMICALS